The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa)
The decision to use oral versus injectable peptides depends on circumstances that vary person to person
Sample size was determined based on practical considerations, prior experience with similar phase 1 study designs, and the objective of obtaining sufficient safety and pharmacokinetic data to support dose escalation decisions
Tracking information remained accurate throughout the process
Subgroup analysis revealed no significant interaction effects across covariates (age, gender, race/ethnicity, education level, marital status, economic status, BMI, smoking/alcohol, hypertension, hyperlipidemia and diabetes), with the RAR-cataract association remaining statistically significant in most subgroups